111 (YI) Interest & Investment Income (2017 - 2025)
111 (YI) posted Interest & Investment Income of $133000.0 for Q4 2025, up 38.54% sequentially from $96000.0 in Q3 2025, and down 33.83% YoY from $201000.0 in Q4 2024.
111 (YI) Interest & Investment Income (2017 - 2025) Analysis & Trends
111 has reported Interest & Investment Income for 9 years, with the latest figure at $133000.0 in Q4 2025.
- Quarterly Interest & Investment Income fell 33.83% year-over-year to $133000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $544000.0 (down 44.32% YoY) and the FY2025 annual result came in at $556000.0, down 42.38% from the prior year.
- Interest & Investment Income climbed to $133000.0 in Q4 2025 per YI's latest filing, from $96000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $476000.0 in Q2 2021 and troughed at $96000.0 in Q3 2025.
- A 5-year average of $273400.0 and a median of $285000.0 in 2023 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2021 and 2025: Interest & Investment Income surged 1058.54% in 2021, then tumbled 55.96% in 2025.
- Over 5 years, Interest & Investment Income stood at $245000.0 in 2021, then rose by 24.08% to $304000.0 in 2022, then increased by 7.24% to $326000.0 in 2023, then tumbled by 38.34% to $201000.0 in 2024, then tumbled by 33.83% to $133000.0 in 2025.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $133000.0, $96000.0, and $142000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | - |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | -140.71 Mn |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | - |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 8.00 Mn |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | -6.30 Mn |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -34.54 Mn |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | 106,000.00 |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | 45,741.00 |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 133,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Dec 31, 2024 | 201,000.00 |
| Sep 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 286,000.00 |
| Mar 31, 2024 | 272,000.00 |
| Dec 31, 2023 | 326,000.00 |
| Sep 30, 2023 | 324,000.00 |
| Jun 30, 2023 | 304,000.00 |
| Mar 31, 2023 | 284,000.00 |
| Dec 31, 2022 | 304,000.00 |
| Sep 30, 2022 | 360,000.00 |
| Jun 30, 2022 | 212,000.00 |
| Mar 31, 2022 | 322,000.00 |
| Dec 31, 2021 | 245,000.00 |
| Sep 30, 2021 | 315,000.00 |
| Jun 30, 2021 | 476,000.00 |
| Mar 31, 2021 | 475,000.00 |